| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Atea Pharmaceuticals Inc (NASDAQ: AVIR)
AVIR Technical Analysis
5
| As on 9th Jun 2023 AVIR STOCK Price closed @ 4.11 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.90 & Strong Sell for SHORT-TERM with Stoploss of 7.17 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AVIRSTOCK Price
| Open | 4.26 | Change | Price | % |
| High | 4.26 | 1 Day | -0.16 | -3.75 |
| Low | 4.10 | 1 Week | 0.12 | 3.01 |
| Close | 4.11 | 1 Month | 0.80 | 24.17 |
| Volume | 428783 | 1 Year | -4.45 | -51.99 |
| 52 Week High 9.43 | 52 Week Low 3.00 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AVIR Daily Charts |
AVIR Intraday Charts |
Whats New @ Bazaartrend |
AVIR Free Analysis |
|
|
AVIR Important Levels Intraday
| RESISTANCE | 4.42 |
| RESISTANCE | 4.32 |
| RESISTANCE | 4.26 |
| RESISTANCE | 4.20 |
| SUPPORT | 4.02 |
| SUPPORT | 3.96 |
| SUPPORT | 3.90 |
| SUPPORT | 3.80 |
AVIR Forecast May 2024
| 4th UP Forecast | 7.79 |
| 3rd UP Forecast | 6.61 |
| 2nd UP Forecast | 5.88 |
| 1st UP Forecast | 5.15 |
| 1st DOWN Forecast | 3.07 |
| 2nd DOWN Forecast | 2.34 |
| 3rd DOWN Forecast | 1.61 |
| 4th DOWN Forecast | 0.43 |
AVIR Weekly Forecast
| 4th UP Forecast | 6.19 |
| 3rd UP Forecast | 5.52 |
| 2nd UP Forecast | 5.11 |
| 1st UP Forecast | 4.70 |
| 1st DOWN Forecast | 3.52 |
| 2nd DOWN Forecast | 3.11 |
| 3rd DOWN Forecast | 2.70 |
| 4th DOWN Forecast | 2.03 |
AVIR Forecast2024
| 4th UP Forecast | 17.31 |
| 3rd UP Forecast | 13.08 |
| 2nd UP Forecast | 10.46 |
| 1st UP Forecast | 7.84 |
| 1st DOWN Forecast | 0.38 |
| 2nd DOWN Forecast | -2.24 |
| 3rd DOWN Forecast | -4.86 |
| 4th DOWN Forecast | -9.09 |
Atea Pharmaceuticals Inc ( NASDAQ USA Symbol : AVIR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AVIR Business Profile
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, a novel antiviral agent that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 that is in Phase I/IIa clinical trial for the treatment of chronic hepatitis C; and AT-889, an investigational, second-generation nucleoside pyrimidine prodrug and other compounds for the treatment of respiratory syncytial virus. It has a Roche License Agreement with F. Hoffmann-La Roche Ltd and Genentech, Inc. for development and commercialization related to AT-527 outside of the United States. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts. Address: 125 Summer Street, Boston, MA, United States, 02110
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service